Guidelines

About this session

27th February

Participants: members of the Algerian Medicines and Pharmaceuticals Agency, Ministry of Pharmaceutical Products, Center of Pharmacovigilance

Recording of the session

Drafting of guidelines: audit of current guidelines, development, codification

Systemic impact of innovation and technologies on guidelines

Budget constraints to be taken into consideration

Following this session , 3 subsequent sessions were organised with Pr. Trouvin to implement in practice what was discussed and lead to the concept papers of the Algerian guidelines on Biosimilars & guidelines for HBPM drugs.

This training was possible thanks to the support of ANPP team and our speakees and not forgetting our sponsor (without conditions) Abbvie